Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129842 · ClinicalTrials.gov registry record
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
A clinical trial of Atrial Fibrillation, sponsored by Itamar-Medical, Israel.
- Completed
- Registry status
- 150
- Enrollment target
- 6
- Study locations
NCT02129842 is a study of Atrial Fibrillation that has completed, run by Itamar-Medical, Israel. The registered enrollment target is 150 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 3 states.
The verdict
NCT02129842, a study of Atrial Fibrillation, has completed, sponsored by Itamar-Medical, Israel.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to assess whether normal endothelial function in patients with Atrial Fibrillation undergoing ablation procedure increases the chances of a favorable clinical outcome and maintaining sinus rhythm following ablation
Conditions Studied
Study Locations (6)
Other
- University Heart Center Hamburg - Hamburg
- Sheba Medical Center - Ramat Gan
- Royal Brompton & Harefield NHS Foundation Trust - London
New York
- New York University School of Medicine - New York
- Icahn School of Medicine at Mount Sinai - New York
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02129842
The ClinicalTrials.gov registry entry for NCT02129842 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The listed sponsor is Itamar-Medical, Israel, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT02129842 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT02129842 about?
NCT02129842 is a clinical study titled "Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?". The purpose of this study is to assess whether normal endothelial function in patients with Atrial Fibrillation undergoing ablation procedure increases the chances of a favorable clinical outcome and maintaining sinus rhythm following ablation
What is the current status of trial NCT02129842?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-05. Estimated completion is 2016-11.
What conditions does trial NCT02129842 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
Who is sponsoring clinical trial NCT02129842?
This trial is sponsored by Itamar-Medical, Israel, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02129842 being conducted?
This trial has 6 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.